Keyphrases
Acute Lymphoblastic Leukemia
100%
Childhood Acute Lymphoblastic Leukemia
61%
L-asparaginase
29%
Pediatric Acute Lymphoblastic Leukemia
28%
Acute Myeloid Leukemia
25%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
24%
Pediatric
23%
Leukemia Patients
22%
Prednisolone
21%
Leukemia
21%
Drug Resistance
20%
Infant Acute Lymphoblastic Leukemia
17%
Pediatric Leukemia
16%
In Vitro Resistance
16%
Methotrexate
16%
Acute Lymphoblastic Leukemia Cells
15%
Childhood Leukemia
13%
Dutch
13%
Daunorubicin
13%
Minimal Residual Disease
12%
Chemotherapy
10%
Survivors
10%
Event-free Survival
10%
Mixed-phenotype Acute Leukemia
10%
Glucocorticoid Resistance
10%
Leukemic Cells
8%
Netherlands
8%
MTT Assay
8%
Neuroblastoma
7%
BCP-ALL
7%
Oncology
7%
Immunophenotyping
7%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
7%
Childhood Cancer
7%
Working Diagnosis
7%
Clinical Outcomes
7%
Childhood Cancer Survivors
7%
Bone Mineral Density
6%
Pediatric Patients
6%
Multidrug Resistance Protein 1 (MDR1)
6%
Prognostic Significance
6%
Long-term Survivors
6%
Prednisone
6%
MicroRNA
6%
Bone Marrow
6%
Children with Cancer
5%
High Risk
5%
Drug Resistance Profiles
5%
Newly Diagnosed
5%
Acute Leukemia
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
87%
Pediatrics
30%
Acute Myeloid Leukemia
20%
Leukemia
18%
Childhood Cancer
17%
In Vitro
16%
Malignant Neoplasm
14%
Drug Resistance
14%
Chemotherapy
11%
Pediatric Acute Myeloid Leukemia
11%
Minimal Residual Disease
9%
B Cell
9%
Prednisolone
8%
Precursor
8%
Ganglioneuroblastoma
8%
Prognostic Factor
7%
Adolescence
7%
Neoplasm
7%
Event Free Survival
7%
Overall Survival
7%
Disease
7%
Leukemia Cell
7%
Acute Leukemia
6%
Oncology
6%
Wilms' Tumor
6%
Vincristine
6%
Gene Expression
5%
Asparaginase
5%